Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Alligo - Winter timing means growth must wait until Q1

22 januari 2026

<a id="bm-comp-8b795a35-e23f-4318-8c23-d435b746440b" name="bm-comp-8b795a35-e23f-4318-8c23-d435b746440b" class="BMCustomAnchor"></a><table><tr><td bm-component-id="8b795a35-e23f-4318-8c23-d435b746440b" style="vertical-align: top; width:100.000000%;"><ul><li>Mild winter in Q4, but sequentially easing comps: organic growth -1%</li><li>Cost savings took effect in Q3, expect y-o-y margin up 0.6pp to 8.9%</li><li>Winter cold hit around 1 January, supports return to growth in Q1</li></ul></td></tr></table><a id="bm-comp-97d8e338-b441-4621-a0f3-42ce106c4c03" name="bm-comp-97d8e338-b441-4621-a0f3-42ce106c4c03" class="BMCustomAnchor"></a><table><tr><td bm-component-id="97d8e338-b441-4621-a0f3-42ce106c4c03" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q4 expectations</h3><p>The winter in Q4 was very mild, which is negative for Alligo due to demand for important product categories such as hydraulics and winter clothing correlating inversely with temperature. However, the winter in the comparison period was also very mild, and given unchanged underlying demand q-o-q and a sequential easing of comparative figures, this leads us to forecast organic growth of -1% vs. -3% in Q3. On the adj. EBITA margin, we expect a y-o-y improvement to 8.9% (8.3%) due to the cost savings that took effect in Q3.</p><h3 class="bm-h3">Estimate changes</h3><p>We only fine-tune our '26-'27 estimates, trimming adj. EBITA by 2%, half of which is due to FX.</p><h3 class="bm-h3">Outlook &amp; valuation</h3><p>Investors are still awaiting the announcement of a successor to outgoing CEO Clein Ullenvik, but in the meantime, cold winter weather hit the Nordics properly around 1 January, boding well for our forecast of a return to organic growth in Q1 (3%) for the first time in 11 quarters. This should support our full-year estimate of 4.5% organic growth, which in turn enables margin expansion from 6.4% to 7.4%, as the drop-through on new volumes should be high. The share is currently trading at a '26e-'27e P/E of 14-11x, and we reiterate our fair value range of SEK 110-200.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-03-08 Medicover - From build-out to fill-up Medicover Analys
2026-03-02 Qben Infra - Portfolio reshaping continues Qben Infra Analys
2026-02-27 Xplora Technologies - Record quarter driven by Se... Xplora Tech.. Analys
2026-02-24 Isofol Medical - From first lessons to second exe... Isofol Medical Analys
2026-02-24 B3 Consulting Group - Cost adjustments should lif... B3 Consulti.. Analys
2026-02-23 Ework Group - Market conditions yet to improve Ework Group Analys
2026-02-23 Formpipe - Good margins, but ACV lags Formpipe Analys
2026-02-23 Energy Save - Back to growth, but softer H1'26 ex... Energy Save Analys
2026-02-23 Fastpartner - Outlook taking a hit Fastpartner Analys
2026-02-23 Cavotec - Industry shines in cautious environment Cavotec Analys
2026-02-20 Arctic Paper - Still challenging Arctic Paper Analys
2026-02-20 Inission - Set for substantial earnings growth Inission Analys
2026-02-20 BTS Group - Ahead of plan on growth recovery BTS Group Analys
2026-02-20 Energy Save - OEM sales up, softer start to '26 e... Energy Save Analys
2026-02-20 Formpipe - Weaker ACV, but higher dividends Formpipe Analys
2026-02-20 B3 Consulting Group - Margin beat on cost cuts B3 Consulti.. Analys
2026-02-20 BTS Group - North America behind Q4 miss BTS Group Analys
2026-02-20 Skolon - Q4'25 momentum to also pay off in H1'26 Skolon Analys
2026-02-20 Ogunsen - Easier comps await in '26e Ogunsen Analys
2026-02-20 Inission - Recovery continues to materialise Inission Analys